Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AlloVir, Inc. stock logo
ALVR
AlloVir
$2.55
-1.2%
$2.68
$7.96
$24.15
$12.86M0.6315,685 shs48,185 shs
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$1.37
+2.2%
$1.58
$1.23
$4.84
$12.62M0.47200,270 shs89,133 shs
MetaVia Inc. stock logo
MTVA
MetaVia
$0.62
+2.9%
$0.68
$0.56
$4.32
$11.75M0.26173,105 shs165,369 shs
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
$0.73
$0.93
$2.22
$13.10
$3.75MN/A108,185 shs22,784 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AlloVir, Inc. stock logo
ALVR
AlloVir
-5.20%-5.20%+2.00%-40.70%-85.36%
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
+2.24%-2.84%-8.05%-22.38%-48.11%
MetaVia Inc. stock logo
MTVA
MetaVia
+2.92%+2.05%-0.74%-13.03%+61,749,900.00%
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
0.00%0.00%0.00%0.00%-36.32%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AlloVir, Inc. stock logo
ALVR
AlloVir
N/AN/AN/AN/AN/AN/AN/AN/A
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.7679 of 5 stars
0.05.00.00.00.02.50.0
MetaVia Inc. stock logo
MTVA
MetaVia
2.1845 of 5 stars
3.50.00.00.02.40.01.3
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AlloVir, Inc. stock logo
ALVR
AlloVir
0.00
N/AN/AN/A
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.00
N/AN/AN/A
MetaVia Inc. stock logo
MTVA
MetaVia
3.00
Buy$7.501,114.57% Upside
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RWOD, BFRG, MTVA, and ALVR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
MetaVia Inc. stock logo
MTVA
MetaVia
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$6.00 ➝ $3.00
(Data available from 8/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AlloVir, Inc. stock logo
ALVR
AlloVir
N/AN/AN/AN/A$29.35 per shareN/A
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
$60K215.09N/AN/A$0.57 per share2.40
MetaVia Inc. stock logo
MTVA
MetaVia
N/AN/AN/AN/A$0.92 per shareN/A
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AlloVir, Inc. stock logo
ALVR
AlloVir
-$190.42M-$20.23N/AN/AN/A-71.03%-61.27%8/7/2025 (Estimated)
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
-$6.99M-$0.81N/AN/AN/A-163.23%-139.94%N/A
MetaVia Inc. stock logo
MTVA
MetaVia
-$27.59MN/A0.00N/AN/AN/A-222.13%-123.85%8/13/2025 (Estimated)
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A

Latest RWOD, BFRG, MTVA, and ALVR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
MetaVia Inc. stock logo
MTVA
MetaVia
-$0.32N/AN/AN/AN/AN/A
5/14/2025Q1 2025
MetaVia Inc. stock logo
MTVA
MetaVia
-$0.57-$0.36+$0.21-$0.36N/AN/A
5/13/2025Q1 2025
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A-$0.21N/A-$0.21N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AlloVir, Inc. stock logo
ALVR
AlloVir
N/AN/AN/AN/AN/A
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/AN/AN/AN/AN/A
MetaVia Inc. stock logo
MTVA
MetaVia
N/AN/AN/AN/AN/A
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AlloVir, Inc. stock logo
ALVR
AlloVir
N/A
86.78
86.78
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
N/A
4.87
4.87
MetaVia Inc. stock logo
MTVA
MetaVia
N/A
1.55
1.55
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AlloVir, Inc. stock logo
ALVR
AlloVir
66.05%
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
0.96%
MetaVia Inc. stock logo
MTVA
MetaVia
1.37%
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
20.07%

Insider Ownership

CompanyInsider Ownership
AlloVir, Inc. stock logo
ALVR
AlloVir
32.07%
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
33.90%
MetaVia Inc. stock logo
MTVA
MetaVia
0.80%
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
2.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
AlloVir, Inc. stock logo
ALVR
AlloVir
1105.04 million3.43 millionOptionable
Bullfrog AI Holdings Inc. stock logo
BFRG
Bullfrog AI
49.42 million6.22 millionNot Optionable
MetaVia Inc. stock logo
MTVA
MetaVia
819.59 million19.43 millionN/A
Redwoods Acquisition Corp. stock logo
RWOD
Redwoods Acquisition
N/A5.17 million5.06 millionNot Optionable

Recent News About These Companies

Redwood Services Makes 19th Acquisition
Redwood Announces Investment by Atlas Partners
Blank-Check Company Cal Redwood Files for IPO
Redwood Empire Whiskey Acquires Luxury Northern California Distillery
Acacia Capital buys Redwood City apartments for $184M
BMW of North America partners with Redwood Materials

New MarketBeat Followers Over Time

Media Sentiment Over Time

AlloVir stock logo

AlloVir NASDAQ:ALVR

$2.55 -0.03 (-1.16%)
As of 08/5/2025

AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.

Bullfrog AI stock logo

Bullfrog AI NASDAQ:BFRG

$1.37 +0.03 (+2.24%)
Closing price 08/6/2025 04:00 PM Eastern
Extended Trading
$1.38 +0.01 (+1.09%)
As of 08/6/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.

MetaVia stock logo

MetaVia NASDAQ:MTVA

$0.62 +0.02 (+2.92%)
As of 08/6/2025 04:00 PM Eastern

MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc., formerly known as NeuroBo Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

Redwoods Acquisition stock logo

Redwoods Acquisition NASDAQ:RWOD

Redwoods Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. In intends to focus on businesses in the carbon neutral and energy storage industries. The company was incorporated in 2021 and is based in New York, New York.